Oxbridge Re Holdings Ltd. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on March 18, 2024, by Oxbridge Re Holdings Limited (the "Company"). The report discloses the commencement of a securities offering by SurancePlus Inc., an indirect wholly-owned subsidiary of the Company. The offering involves the issuance of digital tokens representing "Participation Shares" under a 3-year Participation Share Investment Contract (PSIC).
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the Company or its subsidiaries. The document focuses exclusively on the terms of a new capital raising initiative.
Material Changes and Offering Details
- Security Type: Participation Shares represented by digital tokens labeled "EpsilonCat Re". These are contractual rights, not equity shares in SurancePlus, and carry no preemptive or conversion rights.
- Offering Size: Up to 1,000,000 Participation Shares to be issued at the commencement of the offering.
- Price: Initial offering price of $10.00 per Participation Share.
- Use of Proceeds: Net proceeds will be used by SurancePlus to purchase participating notes from Oxbridge Re NS (an affiliated reinsurance entity). These funds will subsequently be invested in collateralized reinsurance contracts underwritten by Oxbridge Re NS.
- Investor Returns: Holders are entitled to a preferred return equal to the initial price plus 20%, followed by 80% of any proceeds in excess of the preferred return amount.
- Future Issuances: Quantities for 2025 and 2026 will be disclosed prior to issuance.
Guidance, Risks, and Contingencies
The filing contains forward-looking statements regarding the offering and future results, which are subject to risks and uncertainties. Key contingencies and risks include:
- Completion Uncertainty: There is no assurance that the offering of Securities will be completed.
- Registration Status: The Securities are not registered under the Securities Act of 1933. They are being sold under exemptions (Rule 506(c) for U.S. accredited investors and Regulation S for non-U.S. persons).
- Legal Restrictions: The Securities may not be offered or sold in the United States absent an effective registration statement or applicable exemption. The offering is not being made in jurisdictions where it would violate local securities laws.
- Liability Disclaimer: The information in this report is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting liability exposure.
Investor Verification Checklist
- Verify the final terms and total capital raised in the "EpsilonCat Re" offering once the offering period concludes.
- Confirm the specific collateralized reinsurance contracts underwritten by Oxbridge Re NS that will back the participating notes.
- Review the Confidential Private Placement Memorandum for detailed risk factors and legal terms not fully disclosed in this 8-K.
- Monitor future filings for the disclosure of Participation Share quantities for the 2025 and 2026 issuance years.
- Check the Company's Form 10-K (filed March 30, 2023) for the comprehensive "Risk Factors" section referenced in this report.